Bottom line
Is HRVIX a good fund? The bottom line
HRVIX is the Investor Class share class of Heartland Value Plus Fund, an actively managed large value mutual fund from Heartland Group.
Annual fees run 1.22% — about $122 a year on every $10,000 invested, more expensive than 79% of large value funds we track.
It returned +1.1% over one year, +4.0% a year over five years, +7.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $331 million in net assets and 55 holdings, its largest position is Materion Corp (3.4%) and the top 10 make up 29.5% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.22%)
- 5-year return in the bottom quarter of its category
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What HRVIX invests in
The Value Plus Fund seeks long-term capital appreciation and modest current income.
The Value Plus Fund invests primarily in a limited number (generally 40 to 70) of small-capitalization common stocks selected on a value basis. A majority of its assets are generally invested in dividend-paying common stocks. The Fund invests a majority of its assets in companies with market capitalizations consistent with the capitalization range of the Russell 2000 Value Index. As of April 30, 2025, the market capitalization range of the Russell 2000 Value Index was $119.4 million to $7.4 billion. The median market capitalization of the Fund is expected to fluctuate over time depending on Heartland Advisors perceptions of relative valuations, future prospects, and market conditions. The Fund utilizes Heartland Advisors disciplined and time-tested 10 Principles of Value Investing TM framework to identify securities with the potential for appreciation and a potential margin of safety…
From the fund's prospectus (filed Apr 29, 2026).
HRVIX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HRVIX | +1.1% | +4.0% | +7.6% |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What HRVIX costs
On a $10,000 investment, HRVIX's 1.22% expense ratio costs about $122 a year. The prospectus estimates $1,476 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
HRVIX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Materion Corp | 3.37% |
| 2 | Royalty Pharma Plc | 3.22% |
| 3 | Lamar Advertising Co | 3.07% |
| 4 | Littelfuse Inc | 3.03% |
| 5 | Fnb Corp/pa | 3.03% |
| 6 | Associated Banc-corp | 3.02% |
| 7 | Renasant Corp | 2.89% |
| 8 | Seacoast Banking Corp Of Florida | 2.76% |
| 9 | Envista Holdings Corp | 2.59% |
| 10 | Silicon Motion Technology Corp | 2.52% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 29.5% of the fund. See all top 25 holdings and asset mix →